Diaquip

Throughout 2020 Diaquip has been working with the healthcare sectors across the Baltic region, Belarus and Ukraine to supply diagnostics equipment, test kits and related consumables as part of International efforts for COVID response. We have been working with established and new partners in South Korea and China to ensure timely delivery of produc... t through this critical period. Stay Well. Stay Safe. We are all in this together. A distinctive feature of the Medical and Healthcare business sectors is that manufacturers must adhere to a much fuller range of international regulation. Strict standards must be maintained for high levels of quality for their product and to monitor location and shelf life across the distribution of their product. Manufacturers are increasingly held responsible for the behaviour of any related parties within the distribution chain.Most markets include sales to state healthcare organisations and might feature tendering processes. Consequently they are also subject to a larger range of international regulations. The most invasive of these obligations are provided under anti-corruption law, including the Foreign Corrupt Practices Act (USA), Bribery Act (UK) and European Anti-Corruption Directives. Diaquip regularly participates in far-reaching due diligence exercises undertaken by manufactures and by their distributors to satisfy normal requirements under anti-money laundering regulations and standard know-your-customer requirements. Additionally, Manufacturers also have legal obligations to ensure that products are distributed within the correct regions, according to both distributing agreements and State registrations. Individuals within Diaquip are also regulated by their Professional Accreditations and Governing Bodies (including ICAEW, CMI and HM Revenue & Customs) under Money Laundering Regulations.Read More